These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 627719)

  • 1. Immunochemical properties of the murine Ss protein.
    Goldman JN; Gleason KR; Goldman MB
    J Immunol; 1978 Jan; 120(1):225-32. PubMed ID: 627719
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional and biochemical properties of the early classical complement system of mice.
    Goldman MB; Bangalore S; Goldman JN
    J Immunol; 1978 Jan; 120(1):216-24. PubMed ID: 627718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescent assay for complement activation.
    Caporale LH; Gaber SS; Kell W; Götze O
    J Immunol; 1981 May; 126(5):1963-5. PubMed ID: 7217674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1, C4, and C2 components of the classical pathway of complement and regulatory proteins.
    Gigli I; Tausk FA
    Methods Enzymol; 1988; 162():626-39. PubMed ID: 3226327
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification of the fourth, second and fifth components of mouse complement.
    Fukuoka Y; Seino J; Okuda T; Tachibana T
    Immunology; 1984 Mar; 51(3):493-501. PubMed ID: 6698577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
    Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
    J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharide.
    Schultz DR; Loos M; Bub F; Arnold PI
    J Immunol; 1980 Mar; 124(3):1251-7. PubMed ID: 7358983
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation.
    Fearon DT; Austen KF; Ruddy S
    J Immunol; 1973 Dec; 111(6):1730-6. PubMed ID: 4796101
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.
    Phillips JK; Snyderman R; Mergenhagen SE
    J Immunol; 1972 Aug; 109(2):334-41. PubMed ID: 4114826
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.
    Carroll MC; Capra JD
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2424-8. PubMed ID: 276882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
    Laham MN; Caldwell JR; Panush RS
    J Clin Lab Immunol; 1982 Oct; 9(1):39-47. PubMed ID: 6983586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of functional levels of early components of complement to the H-2 complex of mice.
    Goldman MB; Goldman JN
    J Immunol; 1976 Nov; 117(5 Pt 1):1584-8. PubMed ID: 1002990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new haemolytic assay for the second component of complement (C2) in human serum.
    Naish PF; Barratt J; Collins C
    Clin Exp Immunol; 1976 Sep; 25(3):487-9. PubMed ID: 963910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the oligosaccharide units of the fourth component of complement (Ss protein) synthesized by murine macrophages.
    Roos MH; Kornfeld S; Shreffler DC
    J Immunol; 1980 Jun; 124(6):2860-3. PubMed ID: 7373053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation and functional purification of the first seven components of canine hemolytic complement.
    Sargent AU; Johnson SB; Richardson AK
    Immunochemistry; 1976 Oct; 13(10):823-9. PubMed ID: 1002218
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor.
    Ji YH; Fujita T; Hatsuse H; Takahashi A; Matsushita M; Kawakami M
    J Immunol; 1993 Jan; 150(2):571-8. PubMed ID: 8419490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
    Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
    J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.